Build status - In Progress
Search filters

Filters
Clear All

Phase

  • 4
  • 3
  • 1
  • 4
  • 10
  • 20
  • 5
  • 2
  • 20

Found 22 Uterine Fibroids trials

A listing of Uterine Fibroids medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 INFORM Study
18 years - 100 years
All genders
Join a paid research study on health information on social media!The research study is being conducted to understand how health information and misinformation is shared and interacted with through Facebook wall posts, Twitter posts, and Google and YouTube searches. We’re interested in learning more about how people use information on …
 A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease (NefIgArd)
1 years - 100 years
All genders
Phase 3
The research study is being conducted to see how well the investigational drug, Nefecon, works for the treatment of your kidney disease and more specific for patients with "primary immunoglobulin A nephropathy," called IgAN.
 COVID-19 Booster Vaccine Immune Responses
18 years - 89 years
All genders
This study aims to understand the antibody response to any COVID-19 booster vaccine in any person eligible and willing to receive a COVID-19 booster. The goal of this study is to ascertain the immunological responses that follow COVID-19 booster vaccines in a wide range of individuals. Our study is offered to …
 Effects of opioid use disorder and non-fatal overdose on tau pathology; a [18F]PI-2620 PET/CT study
18 years - 60 years
All genders
Phase 2
This study is being conducted to learn more about how opioid use and opioid overdose affects tau levels in the brain. Tau is a protein in the brain that helps stabilize nerve cells structure. We will study tau levels in the brain using a type of Positron Emission Tomography (PET/CT) …
 Pilot Study of a Multi-System Analysis of Opioid Receptor Binding
18 years - 50 years
All genders
This study investigates opioid receptor binding in the brain and body. It aims to understand how these receptors, which are involved in pain reduction and reward experiences, function in different individuals.The study focuses on measuring the binding of a specific type of opioid receptor using a PET/CT scan. This involves …
 Association between early Candida infection (oral thrush) and severe early childhood caries
1 years - 1 years
All genders
Phase 1
The purpose of this study is to determine if children diagnosed with oral thrush in the first year of their life are at higher risk of developing dental caries.
 Healthy Volunteer Study for Herpes Vaccine (BNT163-01)
18 years - 55 years
All genders
Phase 1
The research study is being conducted to determine the best dose of an investigational vaccine called BNT163, and to determine if the vaccine is safe and well-tolerated. An investigational vaccine is a vaccine that is not approved by the US Food and Drug Administration (FDA), for use outside of this …
12 years - 30 years
All genders
We are seeking young people who are concerned about recent changes in mood, thinking or behavior.  This research project aims to increase understanding of mental health concerns in young people and how to prevent the development of a more serious mental illness such as psychosis.
 Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa
12 months or below
All genders
Phase 3
Interventional
This is a single group, treatment, Phase 3, open-label study to assess efficacy, safety, pharmacokinetic (PK), pharmacodynamics (PD) of avalglucosidase alfa in treatment-naïve male and female participants with IOPD. Study details include: Study duration: Screening - up to 4 weeks; Primary Analysis Period (PAP) - 52 weeks; Extended Treatment Period …
18 years - 50 years
Female
Phase 3
This study is intended to demonstrate the contraceptive efficacy of relugolix combination therapy. Myovant is developing relugolix combination therapy for the indications of the management of heavy menstrual bleeding associated with uterine fibroids and pain associated with endometriosis.
1 - 10 of 22